EP Biocomposites Ltd

EP Biocomposites Ltd

$EPBIOWaste ManagementBSE

EP Biocomposites Ltd (EPBIO) last traded at ₹103, a market capitalisation of ₹17.4 crore, on a P/E of 11.9. Over the past 52 weeks the stock has ranged between ₹75.5 and ₹150. EP Biocomposites Ltd last reported results for the quarter ended Mar 2026, with sales of ₹9.57 crore and net profit of ₹1.37 crore. Figures are as of 25 Aug 2026 and are not real time.

EP Biocomposites Ltd share price and key metrics

Current price
₹103
Market cap
₹17.4 cr
Stock P/E
11.9
Book value
₹71.7
ROE
12.9%
ROCE
16.3%
Dividend yield
0.00%
52w high / low
150/75.5

Metrics as of 25 Aug 2026. Not real time.

EP Biocomposites Ltd quarterly results

In the quarter ended Mar 2026, sales were ₹9.57 cr, up 25.9% from ₹7.6 cr a year earlier. Net profit was ₹1.37 cr, up 65.1% year on year.

EP Biocomposites Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales3.453.684.47.044.47.64.079.57
Expenses2.923.264.145.93.916.313.827.58
Operating profit0.530.420.261.140.491.290.251.99
OPM %15.36%11.41%5.91%16.19%11.14%16.97%6.14%20.79%
Other income0.030.130.090.210.050.060.070.07
Interest0.150.050.010.020.170.190.150.19
Depreciation0.050.050.050.050.050.060.050.05
Profit before tax0.360.450.291.280.321.10.121.82
Tax %25.00%33.33%27.59%27.34%34.38%25.45%33.33%24.73%
Net profit0.270.30.220.930.210.830.091.37
EPS (₹)1.611.781.315.531.254.940.548.15

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

EP Biocomposites Ltd annual results

EP Biocomposites Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales2.958.067.1211.4312.0113.64
Operating profit0.461.40.971.411.782.24
OPM %15.59%17.37%13.62%12.34%14.82%16.42%
Net profit0.360.810.581.151.031.46
EPS (₹)72.006.883.456.846.138.68

TTM is the trailing twelve months to the most recent quarter.

EP Biocomposites Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
36%
3 Years
24%
TTM
14%
Compounded Profit Growth
10 Years
%
5 Years
32%
3 Years
36%
TTM
42%
Stock Price CAGR
10 Years
%
5 Years
%
3 Years
-27%
1 Year
-26%
Return on Equity
10 Years
%
5 Years
14%
3 Years
12%
Last Year
13%

EP Biocomposites Ltd shareholding pattern

Promoters held 70.08% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.00%.

EP Biocomposites Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters70.08%70.08%70.08%70.08%70.05%70.08%70.08%70.08%
FIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public29.92%29.92%29.92%29.92%29.95%29.92%29.92%29.91%
No. of shareholders365365382374361356353337

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Track EP Biocomposites Ltd

Cruxal reads every EP Biocomposites Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

EP Biocomposites Ltd (EPBIO) Results, Financials & Share Price | Cruxal